GlassScriptPhysician profile
David Mcguigan
NPI 1699360800
$2,716.41
in general payments reported to CMS, 2019-2025
6 companies · $2,716 in 2025
The $2,716 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,551 · Food and Beverage: $1,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,550.58 |
| Food and Beverage | $1,165.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $2,103.25 | 2025 | Travoprost Intraocular Implant - Idose, Radius Xr, Istent Infinite |
| Alcon Vision LLC | $335.83 | 2025 | Clareon, Tryptyr, Centurion |
| Biotissue Holdings INC. | $137.34 | 2025 | |
| Amgen INC. | $69.37 | 2025 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $39.93 | 2025 | Tecnis Iol |
| Dompe US, INC. | $30.69 | 2025 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mcguigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.